Sanofi Free To Appeal Genentech Patent Ruling
A federal judge in California on Thursday cleared the way for Sanofi-Aventis Deutschland GmbH to appeal a decision that two Genentech Inc.'s cancer drugs do not infringe the pharmaceutical giant's patents....To view the full article, register now.
Already a subscriber? Click here to view full article